Patent Assignment
Reel/Frame 020252/0143
Assignment of Assignor's Interest
Recorded: 2007-12-13
Pages: 15
Assignor
ALZA CORPORATION
Executed: 2007-12-11
Assignee
INTARCIA THERAPEUTICS, INC.
2000 POWELL STREET, SUITE 1640, EMERYVILLE, CALIFORNIA, 94608
Covered Properties
(38)
Sustained Delivery of Leuprolide Using an Implantable System
Patent:
5,728,396 →
Application:
08/791,699 →
Sustained Delivery of an Active Agent Using an Implantable System
Patent:
5,985,305 →
Application:
08/943,007 →
Osmotic Delivery System and Method for Enhancing Start-Up & Performance of Osmotic Delivery Systems
Patent:
6,132,420 →
Application:
08/970,530 →
Beneficial Agent Delivery System with Membrane Plug and Method for Controlling Delivery of Beneficial Agents
Patent:
6,113,938 →
Application:
09/121,835 →
Rate Controlling Membranes for Controlled Drug Delivery Devices
Patent:
6,375,978 →
Application:
09/213,213 →
Osmotic Delivery System with Membrane Plug Retention Mechanism
Patent:
6,270,787 →
Application:
09/217,823 →
Implanter Device for Subcutaneous Implants
Patent:
6,190,350 →
Application:
09/217,824 →
Peptide/Protein Suspending Formulations
Patent:
5,972,370 →
Application:
09/238,159 →
Sustained Delivery of an Active Agent Using an Implantable System
Patent:
6,156,331 →
Application:
09/310,149 →
Sustained Delivery of an Active Agent Using an Implantable System
Patent:
6,261,584 →
Application:
09/366,746 →
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utilizing Such Vehicles
Patent:
7,258,869 →
Application:
09/497,422 →
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
Application:
09/627,531 →
Sustained Delivery of an Active Agent Using an Implantable System
Osmotic Delivery System with Membrane Plug Retention Mechanism
Osmotic Delivery System with Membrane Plug Retention Mechanism
Rate controlling membranes for controlled drug delivery devices
Application:
09/976,228 →
Publication:
US 2002/0034535
Sustained Delivery of an Active Agent Using an Implantable System
Implanter Device for Subcutaneous Implants
Application:
10/191,782 →
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
Application:
10/319,277 →
Publication:
US 2003/0108609
Sustained Delivery of an Active Agent Using an Implantable System
Osmotic delivery device with membrane plug retention mechanism
Application:
10/885,828 →
Publication:
US 2004/0243106
Osmotic delivery system with membrane plug retention mechanism
Application:
10/962,130 →
Publication:
US 2005/0048097
Composition and Dosage Form Comprising an Interferon Particle Formulation and Suspending Vehicle
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
Application:
11/132,830 →
Publication:
US 2005/0266087
Solvent/Polymer Solutions as Suspension Vehicles
Polyoxaester Suspending Vehicles for Use with Implantable Delivery Systems
Implanter
Patent:
402,757 →
Application:
29/081,307 →
Osmotic Delivery System and Method for Enhancing Start-Up and Performance of Osmotic Delivery Systems
Application:
60/030,481 →
Rate Controlling Membranes for Controlled Drug Delivery Devices
Application:
60/068,377 →
Osmotic Delivery System with Membrane Plug Retention Mechanism
Application:
60/068,987 →
Implanter Device for Subcutaneous Implants
Application:
60/068,996 →
Beneficial Agent Delivery System with Membrane Plug and Method for Controlling Delivery of Benificial Agents
Application:
60/070,011 →
Stable Non Aqueous Single Phase Gels Exhibiting Viscous Fluid Characteristics and Formulations Utilizing Such Gels
Application:
60/119,170 →
Sustained Delivery of an Active Agent Using an Implantable System
Application:
60/122,056 →
Composition and dosage form comprising an amphipilic molecule as a suspension vehicle
Application:
60/520,605 →
Enhanced biomolecule stability during transition from hydrophobic suspension vehicle to hydrophilic medium
Application:
60/574,662 →
Solvent/polymer solutions as suspension vehicles
Application:
60/650,225 →
Polyoxaester suspending vehicles for use with implantable delivery systems
Application:
60/662,091 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 19, 2005
From: ELIAZ, ROM EZER; ZHANG, YUANPENG; ROHLOFF, CATHERINE MANYA; WEEKS, ERIC WILLIAM
To: ALZA CORPORATION
Reel/Frame 015594/0243 →
Assignment of Assignor's Interest
Apr 14, 2009
From: KLEINER, LOTHAR W.; GALE, ROBERT M.; BERGGREN, RANDALL G.; TONG, GILBERT T.
To: ALZA CORPORATION
Reel/Frame 022546/0223 →
Security Agreement
Sep 8, 2010
From: INTARCIA THERAPEUTICS, INC.
To: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
Reel/Frame 024953/0525 →
Assignment of Assignor's Interest
Aug 12, 2011
From: DIONNE, KEITH E.; LAUTENBACH, SCOTT D.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026746/0249 →
Assignment of Assignor's Interest
Sep 1, 2011
From: BERRY, STEPHEN A.; FEREIRA, PAMELA J.; DEHNAD, HOUDIN; MUCHNIK, ANNA
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026845/0405 →
Release of Security Interest
Sep 23, 2011
From: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026962/0062 →
Security Agreement
Nov 14, 2012
From: INTARCIA THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 029299/0678 →
Assignment of Assignor's Interest
Mar 6, 2015
From: ECKENHOFF, EXECUTOR OF THE LAST WILL AND TESTAMENT OF JAMES B. ECKENHOFF, BONNIE J.; HOLLADAY, LESLIE A.; LEONARD, JOHN JOSEPH, JR.; LEUNG, IRIS K. M.
To: ALZA CORPORATION
Reel/Frame 035107/0181 →
Assignment of Assignor's Interest
Mar 6, 2015
From: PEERY, JOHN R.; DIONNE, KEITH E.; ECKENHOFF, EXECUTRIX OF THE ESTATE OF JAMES B. ECKENHOFF, DECEASED, BONNIE J.; LANDRAU, FELIX A.
To: ALZA CORPORATION
Reel/Frame 035107/0175 →
Assignment of Assignor's Interest
Mar 17, 2015
From: AYER, RUPAL
To: ALZA CORPORATION
Reel/Frame 035185/0007 →
Release of Security Interest
Oct 23, 2015
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 036942/0544 →
Security Interest
Oct 9, 2019
From: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050673/0020 →
Security Interest
Oct 23, 2019
From: INTARCIA THERAPEUTICS, INC.
To: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C., AS COLLATERAL AGENT
Reel/Frame 050801/0267 →
Release of Security Interest
Jan 29, 2020
From: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C. AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 051739/0453 →
Release of Security Interest
Apr 17, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
Reel/Frame 052433/0001 →